{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:16:54Z","timestamp":1783052214767,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taishan Scholar Foundation of Shandong Province","award":["tsqn202408392"],"award-info":[{"award-number":["tsqn202408392"]}]},{"name":"the Natural Science Foundation of Qingdao City","award":["25-1-1-238-zyyd-jch"],"award-info":[{"award-number":["25-1-1-238-zyyd-jch"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671658"],"award-info":[{"award-number":["81671658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02287-8","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:59:14Z","timestamp":1778158754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal radiomics incorporating intratumoral heterogeneity for prognostic assessment of metastatic outcomes in invasive breast cancer"],"prefix":"10.1186","volume":"28","author":[{"given":"Liwei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2287_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s10278-023-00818-9","volume":"36","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wang L, Dong X, et al. Deep learning radiomics of preoperative breast MRI for prediction of axillary lymph node metastasis in breast cancer. J Digit Imaging. 2023;36:1323\u201331. https:\/\/doi.org\/10.1007\/s10278-023-00818-9.","journal-title":"J Digit Imaging"},{"key":"2287_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford P, Van Den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II\u20142020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2021;79:263\u201382. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.046.","journal-title":"Eur Urol"},{"key":"2287_CR3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"MP Ebctcg","year":"2014","unstructured":"Ebctcg, Mcgale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60488-8.","journal-title":"Lancet"},{"key":"2287_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11914-023-00849-9","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu Y, Wang M, et al. The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil. Curr Osteoporos Rep. 2024;22:28\u201343. https:\/\/doi.org\/10.1007\/s11914-023-00849-9.","journal-title":"Curr Osteoporos Rep"},{"key":"2287_CR5","doi-asserted-by":"publisher","first-page":"18301","DOI":"10.1038\/s41598-023-45438-z","volume":"13","author":"X Zhong","year":"2023","unstructured":"Zhong X, Lin Y, Zhang W, et al. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning. Sci Rep. 2023;13:18301. https:\/\/doi.org\/10.1038\/s41598-023-45438-z.","journal-title":"Sci Rep"},{"key":"2287_CR6","doi-asserted-by":"publisher","first-page":"1542643","DOI":"10.3389\/fonc.2025.1542643","volume":"15","author":"W Fan","year":"2025","unstructured":"Fan W, Cui H, Liu X, et al. Machine learning-based ultrasound radiomics for predicting risk of recurrence in breast cancer. Front Oncol. 2025;15:1542643. https:\/\/doi.org\/10.3389\/fonc.2025.1542643.","journal-title":"Front Oncol"},{"key":"2287_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13058-023-01688-3","volume":"25","author":"Y Yu","year":"2023","unstructured":"Yu Y, Ren W, He Z, et al. Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study. Breast Cancer Res. 2023;25:132. https:\/\/doi.org\/10.1186\/s13058-023-01688-3.","journal-title":"Breast Cancer Res"},{"key":"2287_CR8","doi-asserted-by":"publisher","unstructured":"Zhang D, Dihge L, Bendahl P-O, et al. Deep learning on routine full-breast mammograms enhances lymph node metastasis prediction in early breast cancer. npj Digit Med. 2025;8:425. https:\/\/doi.org\/10.1038\/s41746-025-01831-8.","DOI":"10.1038\/s41746-025-01831-8"},{"issue":"1127","key":"2287_CR9","doi-asserted-by":"publisher","first-page":"20210348","DOI":"10.1259\/bjr.20210348","volume":"94","author":"NYP Mao","year":"2021","unstructured":"Mao NYP, Zhang H, Zhang K, Song X, Xing D, Chu T. Mammography-based radiomics for predicting the risk of breast cancer recurrence: a multicenter study. Br J Radiol. 2021;94(1127):20210348. https:\/\/doi.org\/10.1259\/bjr.20210348.","journal-title":"Br J Radiol"},{"key":"2287_CR10","doi-asserted-by":"publisher","first-page":"e232780","DOI":"10.1148\/radiol.232780","volume":"310","author":"J Donnelly","year":"2024","unstructured":"Donnelly J, Moffett L, Barnett AJ, et al. AsymMirai: Interpretable Mammography-based Deep Learning Model for 1-5-year Breast Cancer Risk Prediction. Radiology. 2024;310:e232780. https:\/\/doi.org\/10.1148\/radiol.232780.","journal-title":"Radiology"},{"key":"2287_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/clpt.2012.63","volume":"92","author":"GZ Ferl","year":"2012","unstructured":"Ferl GZ, Port RE. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data. Clin Pharmacol Ther. 2012;92:118\u201324. https:\/\/doi.org\/10.1038\/clpt.2012.63.","journal-title":"Clin Pharmacol Ther"},{"key":"2287_CR12","doi-asserted-by":"publisher","first-page":"732848","DOI":"10.1155\/2011\/732848","volume":"2011","author":"X Yang","year":"2011","unstructured":"Yang X, Knopp MV. Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol. 2011;2011:732848. https:\/\/doi.org\/10.1155\/2011\/732848.","journal-title":"J Biomed Biotechnol"},{"key":"2287_CR13","doi-asserted-by":"publisher","first-page":"20220305","DOI":"10.1259\/bjr.20220305","volume":"95","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang X, Han P, et al. Nomograms predicting recurrence in patients with triple negative breast cancer based on ultrasound and clinicopathological features. Br J Radiol. 2022;95:20220305. https:\/\/doi.org\/10.1259\/bjr.20220305.","journal-title":"Br J Radiol"},{"key":"2287_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41698-025-01047-9","volume":"9","author":"J Zhu","year":"2025","unstructured":"Zhu J, Xu B, Fan T, et al. Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter study. NPJ Precis Oncol. 2025;9:248. https:\/\/doi.org\/10.1038\/s41698-025-01047-9.","journal-title":"NPJ Precis Oncol"},{"key":"2287_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001593","author":"ZC Jin","year":"2025","unstructured":"Jin ZC, Wei J, Xiao YD, et al. Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204). Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001593.","journal-title":"Hepatology"},{"key":"2287_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01495-5","author":"J Zhang","year":"2025","unstructured":"Zhang J, Li Y, Li Z, et al. Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response. Nat Biomed Eng. 2025. https:\/\/doi.org\/10.1038\/s41551-025-01495-5.","journal-title":"Nat Biomed Eng"},{"key":"2287_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12880-024-01212-9","volume":"24","author":"H Qian","year":"2024","unstructured":"Qian H, Ren X, Xu M, et al. Magnetic resonance imaging-based radiomics was used to evaluate the level of prognosis-related immune cell infiltration in breast cancer tumor microenvironment. BMC Med Imaging. 2024;24:31. https:\/\/doi.org\/10.1186\/s12880-024-01212-9.","journal-title":"BMC Med Imaging"},{"key":"2287_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ijc.35514","volume":"157","author":"J Hou","year":"2025","unstructured":"Hou J, Yang F, Gao Y, et al. MR imaging of breast cancer: Interpretable radiomics analysis to assess treatment response and survival prognosis after neoadjuvant therapy. Int J Cancer. 2025;157:1723\u201333. https:\/\/doi.org\/10.1002\/ijc.35514.","journal-title":"Int J Cancer"},{"key":"2287_CR19","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z, et al. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2023;308:e222830. https:\/\/doi.org\/10.1148\/radiol.222830.","journal-title":"Radiology"},{"key":"2287_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JP O\u2019connor","year":"2015","unstructured":"O\u2019connor JP, Rose CJ, Waterton JC, et al. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res. 2015;21:249\u201357. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0990.","journal-title":"Clin Cancer Res"},{"key":"2287_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Zhao J, et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter study. Breast Cancer Res. 2024;26:160. https:\/\/doi.org\/10.1186\/s13058-024-01921-7.","journal-title":"Breast Cancer Res"},{"key":"2287_CR22","doi-asserted-by":"publisher","first-page":"42222","DOI":"10.1038\/s41598-025-26331-3","volume":"15","author":"M Hu","year":"2025","unstructured":"Hu M, Hu X, Chen W, et al. CT-based intratumoral heterogeneity quantification fusing deep learning radiomics for predicting lymph node metastasis in early-stage lung adenocarcinoma: a multicenter study. Sci Rep. 2025;15:42222. https:\/\/doi.org\/10.1038\/s41598-025-26331-3.","journal-title":"Sci Rep"},{"key":"2287_CR23","doi-asserted-by":"publisher","first-page":"e241628","DOI":"10.1148\/radiol.241628","volume":"315","author":"KP Slavkova","year":"2025","unstructured":"Slavkova KP, Kang R, Kazerouni AS, et al. MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Radiology. 2025;315:e241628. https:\/\/doi.org\/10.1148\/radiol.241628.","journal-title":"Radiology"},{"key":"2287_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13014-025-02605-y","volume":"20","author":"Y Hu","year":"2025","unstructured":"Hu Y, Cai Z, Aierken N, et al. Intra- and peri-tumoral radiomics based on dynamic contrast-enhanced MRI for prediction of benign disease in BI-RADS 4 breast lesions: a multicentre study. Radiat Oncol. 2025;20:27. https:\/\/doi.org\/10.1186\/s13014-025-02605-y.","journal-title":"Radiat Oncol"},{"key":"2287_CR25","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1038\/s41467-024-53450-8","volume":"15","author":"Y Gao","year":"2024","unstructured":"Gao Y, Ventura-Diaz S, Wang X, et al. An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer. Nat Commun. 2024;15:9613. https:\/\/doi.org\/10.1038\/s41467-024-53450-8.","journal-title":"Nat Commun"},{"key":"2287_CR26","doi-asserted-by":"publisher","first-page":"e2413702","DOI":"10.1002\/advs.202413702","volume":"12","author":"YH Huang","year":"2025","unstructured":"Huang YH, Shi ZY, Zhu T, et al. Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. Adv Sci (Weinh). 2025;12:e2413702. https:\/\/doi.org\/10.1002\/advs.202413702.","journal-title":"Adv Sci (Weinh)"},{"key":"2287_CR27","doi-asserted-by":"publisher","first-page":"103460","DOI":"10.1016\/j.ebiom.2021.103460","volume":"69","author":"Y Yu","year":"2021","unstructured":"Yu Y, He Z, Ouyang J, et al. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study. EBioMedicine. 2021;69:103460. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103460.","journal-title":"EBioMedicine"},{"key":"2287_CR28","doi-asserted-by":"publisher","unstructured":"Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11:1236. https:\/\/doi.org\/10.1038\/s41467-020-15027-z.","DOI":"10.1038\/s41467-020-15027-z"},{"key":"2287_CR29","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006. https:\/\/doi.org\/10.1038\/ncomms5006.","journal-title":"Nat Commun"},{"key":"2287_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15300-8","author":"CF Zhai","year":"2025","unstructured":"Zhai CF, Yang X, Qi X, et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics for predicting high-Gleason scores and castration-resistant PCa: retrospective study. BMC Cancer. 2025. https:\/\/doi.org\/10.1186\/s12885-025-15300-8.","journal-title":"BMC Cancer"},{"key":"2287_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13244-025-01956-0","volume":"16","author":"J Shen","year":"2025","unstructured":"Shen J, Li Q, Li L, et al. Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma. Insights Imaging. 2025;16:76. https:\/\/doi.org\/10.1186\/s13244-025-01956-0.","journal-title":"Insights Imaging"},{"key":"2287_CR32","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.1016\/j.acra.2025.09.016","volume":"32","author":"G Zhang","year":"2025","unstructured":"Zhang G, Wang S, Su Y, et al. MRI Based Intratumoral-Peritumoral Habitat Radiomics for Prediction of Overall Survival in Rhabdomyosarcoma: A Multicenter Study. Acad Radiol. 2025;32:7407\u201318. https:\/\/doi.org\/10.1016\/j.acra.2025.09.016.","journal-title":"Acad Radiol"},{"key":"2287_CR33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12967-024-05619-4","volume":"22","author":"M Hong","year":"2024","unstructured":"Hong M, Fan S, Xu Z, et al. MRI radiomics and biological correlations for predicting axillary lymph node burden in early-stage breast cancer. J Transl Med. 2024;22:826. https:\/\/doi.org\/10.1186\/s12967-024-05619-4.","journal-title":"J Transl Med"},{"key":"2287_CR34","doi-asserted-by":"publisher","first-page":"1482020","DOI":"10.3389\/fimmu.2024.1482020","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, Sun S, Deng X, et al. Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model. Front Immunol. 2024;15:1482020. https:\/\/doi.org\/10.3389\/fimmu.2024.1482020.","journal-title":"Front Immunol"},{"key":"2287_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13058-024-01909-3","volume":"26","author":"L Xiong","year":"2024","unstructured":"Xiong L, Tang X, Jiang X, et al. Automatic segmentation-based multi-modal radiomics analysis of US and MRI for predicting disease-free survival of breast cancer: a multicenter study. Breast Cancer Res. 2024;26:157. https:\/\/doi.org\/10.1186\/s13058-024-01909-3.","journal-title":"Breast Cancer Res"},{"key":"2287_CR36","doi-asserted-by":"publisher","first-page":"e222646","DOI":"10.1148\/radiol.222646","volume":"308","author":"T Ramtohul","year":"2023","unstructured":"Ramtohul T, Djerroudi L, Lissavalid E, et al. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers. Radiology. 2023;308:e222646. https:\/\/doi.org\/10.1148\/radiol.222646.","journal-title":"Radiology"},{"key":"2287_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41568-021-00406-5","volume":"22","author":"RL Satcher","year":"2022","unstructured":"Satcher RL, Zhang XH. Evolving cancer-niche interactions and therapeutic targets during bone metastasis. Nat Rev Cancer. 2022;22:85\u2013101. https:\/\/doi.org\/10.1038\/s41568-021-00406-5.","journal-title":"Nat Rev Cancer"},{"key":"2287_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","volume":"101","author":"P Clezardin","year":"2021","unstructured":"Clezardin P, Coleman R, Puppo M, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101:797\u2013855. https:\/\/doi.org\/10.1152\/physrev.00012.2019.","journal-title":"Physiol Rev"},{"key":"2287_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13058-025-02065-y","volume":"27","author":"A Corrado","year":"2025","unstructured":"Corrado A, Lorito N, Anemone A, et al. In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer. Breast Cancer Res. 2025;27:112. https:\/\/doi.org\/10.1186\/s13058-025-02065-y.","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02287-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:24:18Z","timestamp":1783049058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02287-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2287"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02287-8","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No. QYFY WZLL30582). All data were collected and analyzed anonymously. Given the retrospective design and de-identification of patient data, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as the manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}